Your browser is no longer supported. Please, upgrade your browser.
BDSI BioDelivery Sciences International, Inc. monthly Stock Chart
BDSI [NASD]
BioDelivery Sciences International, Inc.
Index- P/E27.54 EPS (ttm)0.14 Insider Own1.50% Shs Outstand101.03M Perf Week-4.76%
Market Cap374.15M Forward P/E8.30 EPS next Y0.46 Insider Trans-15.12% Shs Float98.63M Perf Month21.79%
Income14.80M PEG1.10 EPS next Q0.06 Inst Own75.70% Short Float3.13% Perf Quarter-2.81%
Sales145.90M P/S2.56 EPS this Y74.90% Inst Trans-3.88% Short Ratio3.05 Perf Half Y-20.34%
Book/sh0.95 P/B4.00 EPS next Y123.41% ROA7.20% Target Price- Perf Year-44.28%
Cash/sh1.02 P/C3.73 EPS next 5Y25.00% ROE18.10% 52W Range2.85 - 7.21 Perf YTD-39.87%
Dividend- P/FCF- EPS past 5Y30.30% ROI2.90% 52W High-47.30% Beta0.74
Dividend %- Quick Ratio2.80 Sales past 5Y23.40% Gross Margin83.80% 52W Low33.33% ATR0.19
Employees178 Current Ratio3.20 Sales Q/Q30.00% Oper. Margin14.50% RSI (14)53.20 Volatility4.66% 5.47%
OptionableYes Debt/Eq0.82 EPS Q/Q2550.60% Profit Margin10.20% Rel Volume0.67 Prev Close3.82
ShortableYes LT Debt/Eq0.82 EarningsNov 05 BMO Payout0.00% Avg Volume1.01M Price3.80
Recom1.70 SMA203.25% SMA503.26% SMA200-9.72% Volume674,962 Change-0.52%
Apr-22-20Initiated Northland Capital Outperform $9
Jan-09-20Initiated Piper Sandler Overweight $9
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Apr-22-15Resumed Piper Jaffray Overweight
Nov-20-20 08:30AM  
Nov-17-20 09:40AM  
Nov-11-20 08:30AM  
Nov-07-20 08:02AM  
Nov-06-20 06:00AM  
Nov-05-20 07:00PM  
08:00AM  
Nov-04-20 05:31PM  
05:11PM  
Oct-23-20 08:00AM  
Sep-28-20 10:41AM  
Sep-24-20 10:46AM  
08:31AM  
Sep-14-20 12:06PM  
Sep-11-20 08:00AM  
Sep-04-20 11:31AM  
Sep-03-20 08:00AM  
Aug-10-20 09:08AM  
Aug-06-20 10:05AM  
Aug-05-20 09:05AM  
07:45AM  
Jul-29-20 12:33PM  
Jul-27-20 04:01PM  
Jul-12-20 07:39PM  
Jun-10-20 05:44PM  
Jun-09-20 11:38PM  
Jun-06-20 11:31AM  
May-29-20 12:17PM  
May-26-20 10:43AM  
May-11-20 08:30AM  
May-09-20 05:01PM  
May-08-20 10:52AM  
May-07-20 06:35PM  
04:01PM  
Apr-30-20 12:34PM  
Apr-28-20 08:00AM  
Apr-27-20 12:31PM  
Mar-24-20 10:02PM  
Mar-14-20 08:51AM  
Mar-13-20 09:29AM  
Mar-12-20 08:55PM  
04:01PM  
02:30PM  
Mar-09-20 08:00AM  
Mar-05-20 12:30PM  
Feb-27-20 05:15PM  
Feb-24-20 02:59PM  
Feb-20-20 08:00AM  
Feb-06-20 10:44AM  
Jan-30-20 10:15AM  
Jan-29-20 10:06AM  
Jan-27-20 05:20PM  
10:25AM  
Jan-13-20 08:30AM  
Jan-08-20 12:00PM  
Jan-06-20 08:30AM  
Dec-30-19 09:44AM  
Dec-27-19 07:53PM  
Dec-25-19 12:00PM  
Dec-19-19 08:30AM  
Dec-12-19 11:30AM  
Dec-10-19 10:48AM  
Dec-06-19 12:00PM  
Dec-05-19 09:07AM  
Dec-04-19 11:05AM  
10:06AM  
Dec-03-19 09:16AM  
08:57AM  
Nov-29-19 09:13AM  
Nov-27-19 08:30AM  
Nov-25-19 08:30AM  
Nov-22-19 09:48AM  
Nov-20-19 10:00AM  
Nov-19-19 09:26AM  
Nov-14-19 10:20AM  
Nov-13-19 08:00AM  
07:49AM  
Nov-12-19 05:25PM  
04:01PM  
Nov-07-19 08:00AM  
Nov-06-19 05:38AM  
Nov-05-19 10:31AM  
Nov-04-19 11:08AM  
11:01AM  
Nov-01-19 12:15PM  
08:20AM  
07:45AM  
Oct-30-19 10:00AM  
08:00AM  
Oct-18-19 11:07AM  
08:46AM  
Oct-17-19 08:57AM  
Oct-07-19 02:50PM  
Oct-01-19 08:00AM  
Sep-17-19 04:05PM  
Sep-07-19 09:30AM  
Aug-29-19 08:00AM  
Aug-28-19 07:45AM  
Aug-26-19 08:16PM  
Aug-16-19 01:41AM  
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh VanilaDirectorNov 23Option Exercise0.005,333012,084Nov 27 04:16 PM
Bailey Jeffrey AllenChief Executive OfficerNov 04Option Exercise0.0040,000045,567Nov 06 05:21 PM
Davis Todd CDirectorAug 18Sale4.9950,000249,500217,914Aug 20 04:16 PM
Watson W. MarkDirectorAug 17Sale5.1813,00067,34052,979Aug 19 04:30 PM
Sirgo Mark ADirectorAug 14Sale4.90115,000563,5001,091,095Aug 17 06:58 PM
Sirgo Mark ADirectorAug 13Sale4.5385,000385,0501,206,095Aug 17 06:58 PM
KOTLER KEVINDirectorAug 07Option Exercise0.9845,00043,9504,355,689Aug 11 05:16 PM
Greenleaf PeterDirectorAug 07Option Exercise0.0035,000059,788Aug 11 05:03 PM
Sirgo Mark ADirectorAug 07Option Exercise0.004,00001,291,095Aug 11 04:55 PM
Singh VanilaDirectorAug 07Option Exercise0.006,75106,751Aug 11 04:54 PM
Bailey Jeffrey AllenChief Executive OfficerAug 07Option Exercise0.005,56705,567Aug 11 04:53 PM
Watson W. MarkDirectorAug 07Option Exercise0.0030,000065,979Aug 11 04:51 PM
Davis Todd CDirectorAug 07Option Exercise0.0030,0000267,914Aug 11 04:50 PM
Vollins JamesSee RemarksMay 21Option Exercise3.9021,66684,49721,666May 22 04:04 PM
Vollins JamesSee RemarksMay 21Sale4.6021,66699,6640May 22 04:04 PM
Plesha Scott M.See RemarksMay 18Sale4.5215,00067,800234,003May 20 04:38 PM
ODONNELL FRANCIS E JRDirectorMay 11Option Exercise0.0022,5000628,038May 14 04:07 PM
Sirgo Mark ADirectorMay 11Option Exercise0.0022,50001,287,095May 12 06:48 PM
Sirgo Mark ADirectorMay 08Sale5.07100,000507,0001,264,595May 12 06:48 PM
ODONNELL FRANCIS E JRDirectorMay 06Sale4.5311,25050,963605,538May 08 04:06 PM
Cukier HermChief Executive OfficerMay 04Option Exercise0.0066,6660102,447May 05 04:05 PM
ODONNELL FRANCIS E JRDirectorMay 04Sale4.4516,00071,200616,788May 05 04:06 PM
Sirgo Mark ADirectorApr 27Sale4.58100,000458,0001,364,595Apr 29 04:10 PM
ODONNELL FRANCIS E JRDirectorApr 20Sale4.2220,00084,400632,788Apr 22 04:18 PM
Sirgo Mark ADirectorApr 15Sale4.1350,000206,5001,464,595Apr 17 04:05 PM
Plesha Scott M.See RemarksMar 18Sale3.5515,00053,250249,003Mar 18 04:19 PM
ODONNELL FRANCIS E JRDirectorMar 17Sale3.6330,500110,715656,072Mar 18 04:18 PM
Plesha Scott M.See RemarksMar 16Option Exercise0.0029,1670243,170Mar 18 04:19 PM
ODONNELL FRANCIS E JRDirectorMar 16Option Exercise0.0077,5000688,754Mar 18 04:18 PM
ODONNELL FRANCIS E JRDirectorMar 16Sale3.6038,750139,500686,572Mar 18 04:18 PM
Vollins JamesSee RemarksMar 16Sale3.503,83313,4160Mar 18 04:20 PM
ODONNELL FRANCIS E JRDirectorFeb 03Sale5.318,00042,480548,754Feb 04 07:21 PM
Cukier HermChief Executive OfficerFeb 03Sale5.1631,850164,34635,781Feb 04 07:25 PM
Cukier HermChief Executive OfficerJan 31Option Exercise0.0031,250067,631Feb 04 07:25 PM
Vollins JamesSee RemarksJan 31Option Exercise0.003,83303,833Feb 04 07:19 PM
Smith Thomas BChief Medical OfficerJan 31Option Exercise0.007,66607,666Feb 04 07:31 PM
Plesha Scott M.See RemarksJan 31Option Exercise0.0013,3330205,669Feb 04 07:29 PM
Smith Thomas BChief Medical OfficerJan 31Sale5.382,92715,7474,739Feb 04 07:31 PM
Plesha Scott M.See RemarksJan 21Sale5.7715,00086,550192,336Jan 23 04:28 PM
Coelho Mary TheresaSee RemarksJan 16Sale5.9842,018251,26812,018Jan 17 04:06 PM
Coelho Mary TheresaSee RemarksJan 15Option Exercise2.4654,036133,17254,036Jan 17 04:06 PM
Sirgo Mark ADirectorJan 07Sale5.6513,35375,4441,478,124Jan 09 04:03 PM
Sirgo Mark ADirectorJan 06Sale5.8418,600108,6241,491,477Jan 06 08:48 PM
Sirgo Mark ADirectorJan 03Sale6.0013,85783,1421,510,077Jan 06 08:48 PM
Sirgo Mark ADirectorJan 02Sale6.0954,190330,0171,523,934Jan 06 08:48 PM
ODONNELL FRANCIS E JRDirectorJan 02Sale6.108,00048,800556,754Jan 03 04:23 PM
ODONNELL FRANCIS E JRDirectorDec 26Sale7.0010,00070,000554,754Dec 30 05:40 PM
Broadfin Healthcare Master FunDirectorDec 20Sale6.321,000,0006,320,0002,300,066Dec 20 07:51 PM
Broadfin Healthcare Master FunDirectorDec 18Sale6.491,000,0006,485,0003,300,066Dec 20 07:51 PM
Plesha Scott M.See RemarksDec 11Sale6.3650,000318,000207,336Dec 13 04:07 PM
Cukier HermChief Executive OfficerDec 02Option Exercise2.1838,46183,84574,842Dec 04 04:17 PM
Cukier HermChief Executive OfficerDec 02Sale6.8238,461262,30436,381Dec 04 04:17 PM
ODONNELL FRANCIS E JRDirectorDec 02Sale6.868,00054,880564,754Dec 04 04:13 PM